This section serves as a central repository for key corporate materials intended for our investors, stakeholders, and regulatory partners. We are committed to maintaining the highest standards of transparency, governance, and accountability.
Opportunity-Plus Investment Fund appreciates your continued trust and interest.

The Opportunity-Plus Investment Fund Information Memorandum is a comprehensive document that outlines all key aspects of the fund, including its investment strategy, objectives, structure, management, and risk profile. It serves as the primary source of information for prospective investors, providing transparency around how the fund operates, how capital is deployed, and what returns and risks investors can expect. The memorandum also includes details on fees, distributions, liquidity terms, and legal and regulatory considerations.
This document is intended to support informed investment decisions and must be read carefully before submitting an application to invest. It does not constitute personal financial advice but is essential reading for any individual or entity considering an investment in the Opportunity-Plus Investment Fund. Investors should consult their financial or legal advisers in conjunction with reviewing the Information Memorandum to ensure the investment aligns with their objectives and risk tolerance.

The Non-Disclosure Agreement (NDA) governs the use and protection of confidential information shared by Anti Ordinary. By signing, the recipient agrees to maintain confidentiality, use the information solely for its intended purpose, and comply with all obligations regarding disclosure and protection of proprietary materials. Execution of this NDA is required before any sensitive information is provided.
The documents provided on this page are for informational purposes only and do not constitute an offer to sell or a solicitation of an offer to buy any securities or investment products. Certain materials may contain confidential or proprietary information and are intended solely for the use of existing investors or authorized individuals. Unauthorized distribution, reproduction, or disclosure of any content is strictly prohibited. Please consult with a qualified financial advisor before making any investment decisions.
Connecting institutional, accredited, and high-net-worth investors with carefully vetted opportunities across pharma and agribiotech.
© 2026 Opportunity-Plus Investment Fund (OPIF). All rights reserved.